CancerLinQ Suite

CancerLinQ Suite is a precision oncology support platform developed by ConcertAI, designed to transform real-world patient data into actionable clinical insights directly within electronic health record (EHR) workflows. Built for oncologists and cancer care teams, the suite draws on a network of over 9 million real-world data patients across multiple EHR systems and tumor-specific datasets, enabling evidence-based, personalized treatment decisions at the point of care.

The platform serves subscribing cancer organizations by closing care gaps, supporting clinical trial screening, enabling cohort-level comparisons, and surfacing newly approved therapies — all embedded seamlessly into existing clinical workflows to promote efficiency and improve patient outcomes.

Key Benefits of Participating in CancerLinQ

• Care Gaps: Provides quality measures — including QOPI and ASCO Certified measures — alongside population insights, allowing care teams to monitor and address care quality in near real time.
• Clinical Trials: Offers self-service trial digitization so research teams can quickly onboard protocols without deep informatics expertise, and includes patient-to-trial matching to identify eligible patients for ongoing studies.
• Population Insight: Delivers population-level views to support both strategic enterprise decisions and patient-centric care planning.
• Decision Support: Leverages real-world insights to surface patient-to-cohort comparisons, newly approved therapies, clinical evidence, and guidelines at the right moment within the clinical workflow.

Quality Measures

• Near real-time ASCO quality measure monitoring
• Alerts for actionable patients eligible for quality care interventions
• Automated data abstraction from the most common EHR systems
• Supports QOPI and ASCO Certified quality measure submission

New FDA Approvals — Real-Time Therapy Matching

• Workflow-integrated alerts for newly approved therapies
• Molecular and biomarker-based patient identification
• Longitudinal patient-centric diagnostic, treatment, and lab data
• Supports precision engagement at the healthcare professional level
• Biomarker-driven opportunities surfaced through direct alerts to oncologists when new treatment options match a patient's profile
• Timely therapy updates integrated with diagnostic and EMR data, enabling fast decisions aligned to evolving clinical evidence
• Seamless EHR integration via RxLinQ supports provider workflows without disruption, maximizing adoption and impact

Cohort Matching — Compare Patients, Guide Treatment

• "Patients Like Mine" insights using real-world data
• View outcomes across treatment cohorts
• Embedded directly in the provider EMR workflow
• Structured cohort breakdown and filtering with clinical and genomic comparisons

Trial Matching — AI-Powered Trial Screening

• Patient screening tool designed to streamline identification of next-line therapy options
• Facilitates efficient patient-to-trial matching for CancerLinQ practices
• Self-service trial digitization tools for efficient study management
• Seamless integration into the TriaLinQ platform

CancerLinQ Suite is deployed within existing EHR and EMR environments, ensuring minimal workflow disruption for clinical teams. The platform integrates diagnostic, genomic, and treatment data longitudinally, supporting precision oncology at scale across subscribing cancer organizations.